go back

Promethazine, Oral

Rhode Island rates for HCPCS Q0169

Promethazine HCl, 12.5 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$00%50%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%10th$0$0.0$0.1$0.5$2.0$10.0$50.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.17
Median
$0.33
Typical High
$0.33
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.08
Median
$0.09
Typical High
$0.09
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.08
Median
$0.08
Typical High
$0.09
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.09
Median
$0.09
Typical High
$0.09
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.09
Median
$0.09
Typical High
$0.17
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.09
Median
$0.09
Typical High
$0.09
United
Setting
Professional
Modifier
Global
Typical Low
$0.07
Median
$0.08
Typical High
$0.08